Henry Schein (Nasdaq:HSIC) - 주가, 뉴스 및 분석

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

HSIC 주식 개요

는 전 세계 치과 의사, 실험실, 내과의원, 외래 수술 센터, 정부, 기관 의료 클리닉 및 기타 대체 진료 클리닉에 의료 제품 및 서비스를 제공합니다.

HSIC 기본 분석
눈송이 점수
가치 평가	5/6
미래 성장	3/6
과거 실적	1/6
재무 상태	4/6
배당금	0/6

보상

공정 가치 추정치보다 낮은 59.6% 에서 거래

수익은 매년 24.68% 증가할 것으로 예상됩니다.

동종업계 및 업계 대비 좋은 가치로 거래

위험 분석

부채비율이 높네요

Henry Schein, Inc. 경쟁사

Cardinal Health

NYSE:CAH

US$25.6b

Patterson Companies

NasdaqGS:PDCO

US$2.2b

Cencora

NYSE:COR

US$47.1b

McKesson

NYSE:MCK

US$78.8b

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Henry Schein
과거 주가
현재 주가	US$66.10
52주 최고치	US$82.63
52주 최저치	US$60.01
베타	0.90
11개월 변경	-7.84%
3개월 변경 사항	-12.04%
1년 변경 사항	-17.51%
33년 변화	-10.68%
5년 변화	-4.02%
IPO 이후 변화	1,062.20%

최근 뉴스 및 업데이트

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Apr 14

Recent updates

Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight

May 23

Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden

May 22

Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

May 02

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Apr 14

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Feb 28

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Oct 11

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Sep 23

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Aug 21

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Aug 01

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jul 09

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Jun 09

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

May 21

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

May 01

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Apr 10

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Feb 15

Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled

Jan 28

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jan 10

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Dec 11

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?

Nov 04

Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios

Aug 25

Henry Schein announces $400M increase to stock buyback plan

Aug 18

If EPS Growth Is Important To You, Henry Schein (NASDAQ:HSIC) Presents An Opportunity

Aug 09

Henry Schein Q2 2022 Earnings Preview

Aug 01

Be Wary Of Henry Schein (NASDAQ:HSIC) And Its Returns On Capital

Jul 04

Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet?

Jun 14

Henry Schein: Neutral On Valuation, Covid-19 Sales Slowdown

Jun 09

Henry Schein, Inc. (NASDAQ:HSIC) Shares Could Be 45% Below Their Intrinsic Value Estimate

May 27

Does Henry Schein (NASDAQ:HSIC) Deserve A Spot On Your Watchlist?

May 10

Investors Could Be Concerned With Henry Schein's (NASDAQ:HSIC) Returns On Capital

Apr 04

주주 수익률

	HSIC	US Healthcare	US 마켓
7D	-3.2%	0.4%	-0.3%
1Y	-17.5%	2.1%	22.3%

수익률 대 산업: HSIC 지난 1년 동안 2.4 %를 반환한 US Healthcare 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: HSIC 지난 1년 동안 23.3 %를 반환한 US 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is HSIC's price volatile compared to industry and market?
HSIC volatility
HSIC Average Weekly Movement	3.2%
Healthcare Industry Average Movement	6.7%
Market Average Movement	5.7%
10% most volatile stocks in US Market	15.4%
10% least volatile stocks in US Market	2.9%

안정적인 주가: HSIC 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: HSIC 의 주간 변동성( 3% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
1932	25,000	Stan Bergman	www.henryschein.com

는 전 세계 치과 의사, 실험실, 내과, 외래 수술 센터, 정부, 기관 의료 클리닉 및 기타 대체 진료 클리닉에 의료 제품 및 서비스를 제공합니다. 의료 유통과 기술 및 부가 가치 서비스의 두 가지 부문으로 운영됩니다. 헬스케어 유통 부문은 감염 관리 제품, 핸드피스, 예방제, 인상 재료, 복합재, 마취제, 치아, 치과 임플란트, 석고, 아크릴, 관절, 연마제, 치과 의자, 전달 장치 및 조명, X-레이 용품 및 장비, 개인 보호 장비, 하이테크 및 디지털 복원 장비, 장비 수리 서비스 등 치과 제품을 제공합니다.

Henry Schein, Inc. 기본 사항 요약

Henry Schein 의 수익과 매출은 시가총액과 어떻게 비교하나요?
HSIC 기본 통계
시가총액	US$8.61b
수익(TTM)	US$346.00m
수익(TTM)	US$12.45b

24.5x

P/E 비율

0.7x

P/S 비율

HSIC 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
HSIC 손익 계산서(TTM)
수익	US$12.45b
수익 비용	US$8.54b
총 이익	US$3.91b
기타 비용	US$3.56b
수익	US$346.00m

최근 보고된 수익

Mar 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)	2.70
총 마진	31.38%
순이익 마진	2.78%
부채/자본 비율	47.1%

HSIC 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

HSIC 주식 개요

보상

위험 분석

Henry Schein, Inc. 경쟁사

NYSE:CAH

US$25.6b

NasdaqGS:PDCO

US$2.2b

NYSE:COR

US$47.1b

NYSE:MCK

US$78.8b

가격 내역 및 성능

최근 뉴스 및 업데이트

Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight

Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Recent updates

Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight

Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority interest in TriMed, Inc.

Insider recently sold US$478k worth of stock

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Full year 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc.

Henry Schein Appoints Carole T. Faig as New Independent Director

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. announced delayed 10-Q filing

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority stake in Shield HealthCare, Inc.

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire a majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired a majority stake in Large Practice Sales LLC.

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Insider recently sold US$835k worth of stock

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Executive Vice Chairman & President notifies of intention to sell stock

Executive VP & COO notifies of intention to sell stock

Executive VP recently sold US$1.9m worth of stock

Executive VP notifies of intention to sell stock

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) agreed to acquire SIN - Sistema de Implante Nacional S.A. from Southern Cross Group.

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Independent Director recently sold US$148k worth of stock

Senior VP & Chief Legal Officer notifies of intention to sell stock

Independent Lead Director recently sold US$504k worth of stock

Independent Lead Director notifies of intention to sell stock

Independent Director recently sold US$923k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Henry Schein, Inc. Reports Impairment Charge on Intangible Assets for the Fourth Quarter Ended December 31, 2022

Now 25% undervalued

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein, Inc. (NasdaqGS:HSIC) announces an Equity Buyback for $400 million worth of its shares.

Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled

Henry Schein, Inc. to Report Q4, 2022 Results on Feb 16, 2023